Stock Taper Net Interest Income: Increased to $14.2 million, up 4% from $13.7 million in Q3 2025.
Loan Portfolio: Total principal of approximately $411 million across 26 companies, with a weighted average yield to maturity of 16.3%.
Distributable Earnings: Approximately $0.44 per share for Q4, with annual figures at $1.92 (basic) and $1.88 (fully diluted).
Dividends: Fourth quarter dividend declared at $0.47 per share, with total dividends distributed since inception at $8.47 per share.
Leverage: Total leverage at 32% of book equity, down from 33% in Q3.
CECL Reserve: Approximately $5.1 million, representing 1.23% of outstanding loans.
Pipeline: Strong pipeline of $616 million, indicating robust demand for growth capital in the cannabis sector.
Loan Activity: Closed on a credit facility supporting the largest cannabis ESOP to date; significant advances made to existing borrowers.
Regulatory Developments: Positive momentum in cannabis policy, including President Trump's executive order to reclassify cannabis, potentially improving industry economics without increasing lending competition.
Portfolio Protection: 91% of the loan portfolio is insulated from interest rate declines due to high interest rate floors and minimal exposure to floating rates.
Growth Expectations: Targeting net portfolio growth for 2026, with confidence in executing the pipeline.
Dividend Policy: Expecting to maintain a dividend payout ratio of 90% to 100% of distributable earnings for the 2026 tax year, with potential for special dividends if taxable income requires it.
Nonaccrual Loans: Two new nonaccrual loans in Arizona related to the same sponsor, indicating challenges in the local market.
Market Competition: Despite a strong pipeline, there is currently no increase in competition from new lenders, which may limit growth opportunities.
Repayment Uncertainty: Difficulty in forecasting repayments from the portfolio, which could impact net portfolio growth.
Pipeline Execution: Management expressed confidence in executing the pipeline but noted liquidity constraints relative to opportunities.
Impact of Rescheduling: Rescheduling of cannabis has increased demand for debt capital but has not yet affected pricing or underwriting standards.
Loan Number Nine: Additional funding to a troubled borrower was justified by improved cash flow and operational restructuring, though it remains on nonaccrual status for conservatism.
Market Dynamics: Management highlighted that regulatory changes could improve credit conditions, but skepticism remains regarding the sustainability of current cash flow dynamics for cannabis companies. This summary provides a balanced view of Chicago Atlantic Real Estate Finance, Inc.'s performance and outlook, highlighting both strengths and areas of concern as discussed in the Q4 2025 earnings call.
SOURCE: Q4 2025 EARNINGS CALL TRANSCRIPT